Get the Stockscreener App
4.86
3.76%
-0.19
After Hours:
4.86
Lifecore Biomedical Inc stock is traded at $4.86, with a volume of 252.41K.
It is down -3.76% in the last 24 hours and down -13.68% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$5.05
Open:
$5.03
24h Volume:
252.41K
Relative Volume:
1.00
Market Cap:
$182.30M
Revenue:
$147.12M
Net Income/Loss:
$-33.88M
P/E Ratio:
-10.11
EPS:
-0.4805
Net Cash Flow:
$-13.62M
1W Performance:
-7.43%
1M Performance:
-13.68%
6M Performance:
-38.40%
1Y Performance:
-40.88%
1-Day Range:
$4.80
$5.13
1-Week Range:
$4.80
$5.50
52-Week Range:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
4.86 | 189.42M | 147.12M | -33.88M | -13.62M | -0.4805 |
TAK
Takeda Pharmaceutical Co Adr
|
16.96 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.84 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.65 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.29 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
563.70 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
View All
Lifecore Biomedical Inc Stock (LFCR) Latest News
Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India
Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView
Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan
[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan
(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance
Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review
12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey
Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView
Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView
Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView
Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView
LFCR Forecast — Price Target — Prediction for 2027 - TradingView
LDE Forecast — Price Target — Prediction for 2027 - TradingView
LFCR Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesEnergy Earnings Report - dars.gov.et
How (LFCR) Movements Inform Risk Allocation Models - Stock Traders Daily
LFCR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock Edges HigherAnnual Report - dars.gov.et
Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifecore Biomedical Inc (LFCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lifecore Biomedical Inc (LFCR) Institutional Confidence - TradingKey
Lifecore Biomedical Inc (LFCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lifecore Biomedical Inc (LFCR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lifecore Biomedical Inc (LFCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lifecore Biomedical signs manufacturing deal for neurology product By Investing.com - Investing.com Nigeria
Lifecore Biomedical signs manufacturing deal for neurology product - Investing.com
Lifecore Biomedical Signs Agreement for Tech Transfer and Commercial Production of Neurological Injectable Product - Quiver Quantitative
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company - GlobeNewswire
LFCR Q1 2026 Earnings: Wider-than-Expected Loss Weighs on Investor SentimentPreliminary Results - newsline.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook - Yahoo Finance
Trading Systems Reacting to (LFCR) Volatility - Stock Traders Daily
Lifecore Biomedical (LFCR) director awarded 25,907 RSUs - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock award - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907 restricted stock units - Stock Titan
Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock unit grant - Stock Titan
Lifecore Shareholders Approve New 2026 Stock Incentive Plan - TipRanks
Lifecore Biomedical (NASDAQ: LFCR) wins approval for 2026 stock plan - Stock Titan
LFCR Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock Rises Despite WeaknessAnnual Financial Report - newsline.com
Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic - Contract Pharma
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):